SALA, GESSICA
 Distribuzione geografica
Continente #
NA - Nord America 12.166
AS - Asia 6.049
EU - Europa 5.933
SA - Sud America 890
Continente sconosciuto - Info sul continente non disponibili 479
AF - Africa 152
OC - Oceania 10
Totale 25.679
Nazione #
US - Stati Uniti d'America 11.564
SG - Singapore 1.991
IT - Italia 1.713
CN - Cina 1.385
VN - Vietnam 924
DE - Germania 821
RU - Federazione Russa 712
BR - Brasile 668
HK - Hong Kong 659
SE - Svezia 618
CA - Canada 466
IE - Irlanda 400
GB - Regno Unito 369
UA - Ucraina 317
IN - India 257
FR - Francia 216
FI - Finlandia 176
AT - Austria 148
BD - Bangladesh 117
KR - Corea 111
PL - Polonia 89
TR - Turchia 83
NL - Olanda 81
AR - Argentina 76
ES - Italia 72
ID - Indonesia 71
IQ - Iraq 71
MX - Messico 67
JP - Giappone 64
PK - Pakistan 58
DK - Danimarca 49
PH - Filippine 46
BE - Belgio 43
ZA - Sudafrica 40
IR - Iran 39
CO - Colombia 35
EC - Ecuador 32
VE - Venezuela 26
EG - Egitto 25
SA - Arabia Saudita 25
CH - Svizzera 22
UZ - Uzbekistan 21
KE - Kenya 19
MY - Malesia 19
JM - Giamaica 18
ET - Etiopia 16
PY - Paraguay 16
MA - Marocco 15
LT - Lituania 14
CL - Cile 13
AE - Emirati Arabi Uniti 11
CR - Costa Rica 11
CZ - Repubblica Ceca 11
JO - Giordania 11
PT - Portogallo 10
EU - Europa 9
PE - Perù 9
TW - Taiwan 9
DZ - Algeria 8
IL - Israele 8
NP - Nepal 8
AU - Australia 7
GR - Grecia 7
HN - Honduras 7
OM - Oman 7
SY - Repubblica araba siriana 7
TN - Tunisia 7
UY - Uruguay 7
KZ - Kazakistan 6
RO - Romania 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
LB - Libano 5
LV - Lettonia 5
LY - Libia 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
KG - Kirghizistan 4
NI - Nicaragua 4
PA - Panama 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
AL - Albania 3
BB - Barbados 3
BZ - Belize 3
CY - Cipro 3
GE - Georgia 3
GT - Guatemala 3
MU - Mauritius 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
BH - Bahrain 2
BS - Bahamas 2
EE - Estonia 2
GA - Gabon 2
Totale 25.173
Città #
Ann Arbor 1.609
Singapore 1.177
Ashburn 1.155
San Jose 737
Woodbridge 679
Hong Kong 629
Milan 562
Chandler 545
Frankfurt am Main 521
Houston 510
Fairfield 392
Dublin 383
Jacksonville 352
Wilmington 323
New York 313
Toronto 308
Santa Clara 290
Ho Chi Minh City 278
Dallas 264
Dearborn 264
Los Angeles 229
Council Bluffs 218
Hanoi 210
Beijing 191
Seattle 178
Princeton 152
Chicago 149
Cambridge 139
Vienna 129
The Dalles 119
Shanghai 112
Rome 111
Hefei 107
Nanjing 96
Boardman 93
Columbus 89
Seoul 87
Lauterbourg 78
Buffalo 77
São Paulo 70
Helsinki 69
Lachine 61
Moscow 58
Altamura 54
Munich 54
Guangzhou 52
Phoenix 51
Da Nang 50
Jakarta 47
Lawrence 47
Orem 47
London 45
Kraków 44
Brussels 41
Chennai 38
Tokyo 38
Fremont 37
Turin 37
Haiphong 35
Montreal 34
Changsha 33
Shenyang 33
Pisa 32
North Bergen 30
San Diego 30
Atlanta 29
Brooklyn 29
Secaucus 29
Warsaw 29
Nanchang 28
San Francisco 28
Turku 28
Jinan 27
Tianjin 27
Dong Ket 26
Denver 25
Monza 25
Newark 25
Rio de Janeiro 25
Andover 24
Baghdad 24
Pune 24
Zhengzhou 23
Amsterdam 22
Biên Hòa 22
Falls Church 22
Hebei 22
Piscataway 22
Grafing 21
Lahore 21
Ottawa 21
Zurich 21
New Delhi 20
Poplar 20
Belo Horizonte 19
Jiaxing 19
Johannesburg 19
Lecco 19
Manchester 19
Stockholm 18
Totale 15.844
Nome #
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 673
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 557
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 512
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 468
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 448
A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis 445
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 421
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 405
Digested Cinnamon (Cinnamomum verum J. Presl) Bark Extract Modulates Claudin-2 Gene Expression and Protein Levels under TNFα/IL-1β Inflammatory Stimulus 396
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 380
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 378
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 370
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 366
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 364
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 363
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 363
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 356
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 345
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 344
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 339
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 336
New insights into the genetic etiology of Alzheimer's disease and related dementias 335
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 334
Reduced platelet glutamate uptake in Parkinson's disease 332
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 331
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 330
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 324
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 323
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 322
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 321
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 316
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 313
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 312
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 312
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 306
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 305
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 301
Ischemic injury elicits the unconventional secretion of protein hallmarks of Alzheimer's disease onset as seeds for interneuronal propagation 296
Nerve growth factor and transforming growth factor-β serum levels in acute stroke patients: Possible involvement of neurotrophins in cerebrovascular disease 293
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease 292
Exploring the role of autophagy in the pathogenesis of rotenone-induced toxicity 292
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 291
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 290
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 290
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 284
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 281
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 280
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 277
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 276
Alpha-Synuclein, Oxidative Stress and Autophagy Failure: Dangerous Liaisons in Dopaminergic Neurodegeneration 275
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 272
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 266
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 265
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 265
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro 263
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 261
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 260
the MonzALS collaborative network 259
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 259
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 256
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 253
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 251
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 249
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins 244
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases 239
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 230
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 226
Macroautophagy is not altered in ALS lymphomonocytes 226
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis 222
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 219
Analysis of glutamate transporters in peripheral cells: A tool to invistigate excitotoxicity in neurodegenerative disorders 211
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 207
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 197
Increased interleukin-6 release from peripheral blood cells of patients after brain trauma 197
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 195
Assessing glutamatergic function and dysfunction in peripheral tissues 193
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 191
Whole-blood global DNA methylation and phenotypic variability in ALS 182
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 180
Recent advances in the therapy of amyotrophic lateral sclerosis: Focus on excitotoxicity 176
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 176
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro (Scientific Reports, (2021), 11, 1, (2197), 10.1038/s41598-021-81693-8) 175
Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction? 168
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 168
Platelets 142
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 135
Multicenter Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS BASIC) 119
Effects of multidomain interventions on health outcomes in older adults: A systematic review and meta-analysis 59
NMR-based metabolic profiling of human plasma for the identification of biomarkers associated with ageing 56
Pragmatic cluster-randomised trial of a multidomain intervention to prevent hospital-acquired disability: the OPTIMAge-IT study protocol 41
Cholesterol in amyotrophic lateral sclerosis: a bystander, a biomarker, or a target? 37
Identification of ageing-related biomarkers through NMR metabolic profiling of human plasma. 18
null 8
Totale 25.679
Categoria #
all - tutte 78.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.182


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022897 0 0 109 100 81 113 45 57 50 69 108 165
2022/20232.119 190 615 193 239 163 321 26 117 144 17 50 44
2023/20241.674 81 79 104 88 201 456 239 90 79 14 31 212
2024/20253.377 170 407 276 135 253 185 161 139 318 549 278 506
2025/20269.574 1.107 571 689 934 1.000 463 1.474 403 908 893 566 566
2026/20271.115 344 470 301 0 0 0 0 0 0 0 0 0
Totale 25.679